Sarkar, Fazlul H.

Antioxidant effect of zinc in humans

Prasad, A. S., Bao, B., Beck, F. W. J., Kucuk, O., & Sarkar, F. H. (2004) · Free Radical Biology and Medicine

Trace Elements in HealthAntioxidant Activity and Oxidative Stress

Cited by 520

Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients

Bao, B., Prasad, A. S., Beck, F. W. J., Snell, D., Suneja, A., Sarkar, F. H., Doshi, N., Fitzgerald, J. T., & Swerdlow, P. (2008) · Translational Research

Hemoglobinopathies and Related DisordersTrace Elements in Health

Cited by 187

Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-κB

Prasad, A. S., Bao, B., Beck, F. W. J., & Sarkar, F. H. (2011) · Nutrition

NF-κB Signaling PathwaysTrace Elements in Health

Cited by 182

Soy isoflavone supplementation in healthy men prevents NF-κB activation by TNF-α in blood lymphocytes

Davis, J. N., Kucuk, O., Djuric, Z., & Sarkar, F. H. (2001) · Free Radical Biology and Medicine

Phytoestrogen effects and researchGenomics, phytochemicals, and oxidative stress

Cited by 150

Zinc activates NF-κB in HUT-78 cells

Prasad, A. S., Bao, B., Beck, F. W. J., & Sarkar, F. H. (2001) · Journal of Laboratory and Clinical Medicine

NF-κB Signaling PathwaysTrace Elements in Health

Cited by 94

MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function

Azmi, A. S., Aboukameel, A., Banerjee, S., Wang, Z., Mohammad, M., Wu, J., Wang, S., Yang, D., Philip, P. A., Sarkar, F. H., et al. (2010) · European Journal of Cancer

Cancer-related Molecular PathwaysPancreatic and Hepatic Oncology Research

Cited by 67

Zinc enhances the expression of interleukin-2 and interleukin-2 receptors in HUT-78 cells by way of NF-κB activation

Prasad, A. S., Bao, B., Beck, F. W. J., & Sarkar, F. H. (2002) · Journal of Laboratory and Clinical Medicine

Trace Elements in HealthNF-κB Signaling Pathways

Cited by 65

Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors

Azmi, A. S., Banerjee, S., Ali, S., Wang, Z., Bao, B., Beck, F. W. J., Maitah, M., Choi, M., Shields, T. F., Philip, P. A., et al. (2011) · Oncotarget

Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer

Cited by 48